Why the study?
Bleeding and cerebral ischemic events are frequent complications after TAVI, and the optimal antithrombotic therapy to manage these patients remains uncertain.
What is the optimal antithrombotic therapy in patients undergoing transcatheter aortic valve implantation?
What is the optimal antithrombotic therapy in patients undergoing transcatheter aortic valve implantation?
Answers are grounded in this paper and cite their sources.
While guidelines support DAPT after TAVI, recent evidence suggests aspirin alone may reduce bleeding without compromising efficacy, and oral anticoagulants may be needed to prevent valve thrombosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gargiulo et al. (2016) conducted a review in Severe aortic stenosis. Antithrombotic therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: